BG
MYOK

Bellevue Group’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bellevue Group’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,128,400
Closed -$154M – 232
2020
Q3 		$154M Sell
1,128,400
-79,913
-7% -$8.5M 2.13% 10
2020
Q2 		$117M Sell
1,208,313
-103,400
-8% -$8.63M 1.65% 14
2020
Q1 		$61.5M Buy
1,311,713
+5,400
+0.4% +$346K 1.19% 23
2019
Q4 		$95.2M Buy
1,306,313
+13,800
+1% +$837K 1.51% 18
2019
Q3 		$67.4M Buy
1,292,513
+27,600
+2% +$1.47M 1.25% 22
2019
Q2 		$63.4M Buy
+1,264,913
New +$61.6M 1.08% 29

Bellevue Group's MYOK Position: Q4 2020 in Review

Bellevue Group sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 1,128,400 shares — an estimated $154M sold.

Bellevue Group first reported a position in MYOK in Q2 2019 and held it in 6 quarters. The position peaked at $154M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Bellevue Group reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Bellevue Group sold 1,128,400 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $154M.
  • Bellevue Group first reported a position in MyoKardia, Inc. Common Stock in Q2 2019 and held it in 6 quarters.
  • Bellevue Group's MyoKardia, Inc. Common Stock position peaked at $154M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Bellevue Group's 13F filing for Q4 2020, filed 16 Feb 2021.